Instance (Biotechnology) Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Seed
- Investors
-
3
Instance (Biotechnology) General Information
Description
Developer of a biological data generation platform designed to produce functional biological datasets for computational modeling. The company's platform ingests user-provided biological designs, applies configurable generation pipelines to produce standardized functional outputs, and delivers datasets that can be used to train and evaluate models, with documentation, project-based engagement, and data delivery suited for large batch runs, enabling biology and machine-learning teams to obtain task-specific functional training data at scale and reduce time spent on dataset creation.
Contact Information
Website
instance.bioCorporate Office
- 135 Mississippi Street
- San Francisco, CA 94107
- United States
Corporate Office
- 135 Mississippi Street
- San Francisco, CA 94107
- United States
Instance (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Jun-2024 | Completed | Startup |
Instance (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Instance (Biotechnology) Patents
Instance (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026213306-A1 | Compositions for polynucleotide synthesis and uses thereof | Pending | 02-Apr-2025 | ||
| WO-2026213302-A1 | Methods of geometric synthesis | Pending | 02-Apr-2025 | ||
| EP-4784779-A1 | Ultra-high capacity dna synthesis to power functionally generative biological design | Pending | 26-Sep-2023 | ||
| WO-2025072262-A1 | Ultra-high capacity dna synthesis to power functionally generative biological design | Inactive | 26-Sep-2023 | C12N15/1027 |
Instance (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Instance (Biotechnology) Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BlueBox Ventures | Venture Capital | Minority | ||
| Root Ventures | Venture Capital | Minority | ||
| Union Square Ventures | Venture Capital | Minority |
Instance (Biotechnology) FAQs
-
When was Instance (Biotechnology) founded?
Instance (Biotechnology) was founded in 2023.
-
Where is Instance (Biotechnology) headquartered?
Instance (Biotechnology) is headquartered in San Francisco, CA.
-
What is the size of Instance (Biotechnology)?
Instance (Biotechnology) has 10 total employees.
-
What industry is Instance (Biotechnology) in?
Instance (Biotechnology)’s primary industry is Biotechnology.
-
Is Instance (Biotechnology) a private or public company?
Instance (Biotechnology) is a Private company.
-
What is Instance (Biotechnology)’s current revenue?
The current revenue for Instance (Biotechnology) is .
-
Who are Instance (Biotechnology)’s investors?
BlueBox Ventures, Root Ventures, and Union Square Ventures have invested in Instance (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
